Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction
- PMID: 17125407
- DOI: 10.1517/17425255.2.6.875
Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction
Abstract
Animal models are commonly used in the preclinical development of new drugs to predict the metabolic behaviour of new compounds in humans. It is, however, important to realise that humans differ from animals with regards to isoform composition, expression and catalytic activities of drug-metabolising enzymes. In this review the authors describe similarities and differences in this respect among the different species, including man. This may be helpful for drug researchers to choose the most relevant animal species in which the metabolism of a compound can be studied for extrapolating the results to humans. The authors focus on CYPs, which are the main enzymes involved in numerous oxidative reactions and often play a critical role in the metabolism and pharmacokinetics of xenobiotics. In addition, induction and inhibition of CYPs are compared among species. The authors conclude that CYP2E1 shows no large differences between species, and extrapolation between species appears to hold quite well. In contrast, the species-specific isoforms of CYP1A, -2C, -2D and -3A show appreciable interspecies differences in terms of catalytic activity and some caution should be applied when extrapolating metabolism data from animal models to humans.
Similar articles
-
Human hepatic cell cultures: in vitro and in vivo drug metabolism.Altern Lab Anim. 2003 May-Jun;31(3):257-65. doi: 10.1177/026119290303100307. Altern Lab Anim. 2003. PMID: 15612868
-
Cytochrome P450-mediated metabolism in the human gut wall.J Pharm Pharmacol. 2009 May;61(5):541-58. doi: 10.1211/jpp/61.05.0002. J Pharm Pharmacol. 2009. PMID: 19405992 Review.
-
Cytochromes P450 and experimental models of drug metabolism.J Cell Mol Med. 2002 Apr-Jun;6(2):189-98. doi: 10.1111/j.1582-4934.2002.tb00186.x. J Cell Mol Med. 2002. PMID: 12169204 Free PMC article. Review.
-
Involvement of enzymes other than CYPs in the oxidative metabolism of xenobiotics.Expert Opin Drug Metab Toxicol. 2006 Dec;2(6):895-921. doi: 10.1517/17425255.2.6.895. Expert Opin Drug Metab Toxicol. 2006. PMID: 17125408 Review.
-
Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.Curr Drug Metab. 2006 Feb;7(2):165-82. doi: 10.2174/138920006775541552. Curr Drug Metab. 2006. PMID: 16472106 Review.
Cited by
-
Across-species meta-analysis of dexamethasone pharmacokinetics utilizing allometric and scaling modeling approaches.Biopharm Drug Dispos. 2021 May;42(5):191-203. doi: 10.1002/bdd.2266. Epub 2021 Mar 17. Biopharm Drug Dispos. 2021. PMID: 33638217 Free PMC article.
-
Metabolic Profile of 3-Acetyl-11-Keto-β-Boswellic Acid and 11-Keto-β-Boswellic Acid in Human Preparations In Vitro, Species Differences, and Bioactivity Variation.AAPS J. 2016 Sep;18(5):1273-1288. doi: 10.1208/s12248-016-9945-7. Epub 2016 Jun 21. AAPS J. 2016. PMID: 27329304
-
The new pig on the block: modelling cancer in pigs.Transgenic Res. 2013 Aug;22(4):673-80. doi: 10.1007/s11248-013-9720-9. Epub 2013 Jun 8. Transgenic Res. 2013. PMID: 23748932 Review.
-
Exposure to persistent organic pollutants alters the serum metabolome in non-obese diabetic mice.Metabolomics. 2022 Nov 3;18(11):87. doi: 10.1007/s11306-022-01945-0. Metabolomics. 2022. PMID: 36329300 Free PMC article.
-
Liver-on-chips for drug discovery and development.Mater Today Bio. 2024 Jul 2;27:101143. doi: 10.1016/j.mtbio.2024.101143. eCollection 2024 Aug. Mater Today Bio. 2024. PMID: 39070097 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical